65,437 trials
Meningitis, Meningococcal
Primary: Adjusted Human Serum Bactericidal Activity (hSBA) Geometric Mean Titers (GMTs) Against N. Meningitidis Serogroup A for Each Vaccine Group and Between-group Ratios…
X-linked Hypophosphatemia
Primary: Safety and Efficacy of Repeated SC Injections of KRN23. — 21; 1; 1; 13 Participants
Diarrhea
Primary: Percent of Patients With Return Toward a Normal Fecal Bile Acid Pattern — 100 percentage of participants
COPD · Emphysema
Primary: Changes in EQ ED From Baseline to 3 Months Endpoint — 0.06; 0.04 score on a scale
Alzheimer Disease
Primary: Number of Participants Who Completed Rs-fMRI — 4 Participants
Thromboembolism
Primary: Number of Participants With Suspected Adverse Drug Reactions (ADRs) and Fatal Adverse Events (AEs) — 0; 0 Participants
Fetal Alcohol Spectrum Disorders
Primary: BrainHQ Learning Rate — 867.6; 861.7 milliseconds
HIV Infections
Primary: Part 1: Maximum Change From Baseline in Plasma Human Immunodeficiency Virus-1 (HIV-1) Ribonucleic Acid (RNA) at Day 11 — -8605.8; -100719.8; -3406.5 Copies per milliliter
Acute Bronchiolitis
Primary: Time Taken to Reach the Normal Range for Heart Rate (Per-protocol Analysis) — 12; 2 hour — p=<0.001
Primary Immunodeficiency · Agammaglobulinemia · Hypogammaglobulinemia
Primary: Incidence of Acute, Serious Bacterial Infections in the Total ITT Population. — 0.04 ASBI's/person-year
First-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus or
Primary: Median Overall Survival — 4.3; 13.8; 14.6; 15.2 Months
Medical Education
Primary: Percentage Change in Multiple-choice Question (MCQ) Scores — 40; 45 percentage of MCQ change
Prostate Cancer
Primary: Decline in Serum PSA — 4; 10 participants
Visual Acuity
Primary: Percentage of Participants With Lens Centration — 97.3; 91.9 Percentage of participants
Asthma
Primary: Inter-rater Reliability for the Hospital Asthma Severity Score (HASS) — 29 percentage of agreement between raters